state-of-the-art antibody technologies
Craft an original in advanced diagnosis, effective prophylaxis, and therapy
Craft an original in advanced diagnosis, effective prophylaxis, and therapy
We are visionary in designing innovative product-market fit through a combined deep understanding and integration of science and ingenuity.
We craft an original, innovative product via our custom design workflow to make our vision come to life.
Our team successfully developed potent broadly human anti-SARS-CoV-2 antibodies from elite responders. The developed antibodies were licensed to Hibiocy Co. Ltd, which further developed into a nasal spray medical device named VAILL COVITRAP™. The Thai FDA has approved VAILL COVITRAP™ as a Class 4 medical device, making Thailand the first country to approve the manufacturing of human monoclonal antibody-based COVID-19 nasal spray.
Email us at info@biogenexis.com
Monday - Friday: 8:00am - 5:00pm
Saturday - Sunday: Closed
Copyright © 2022 Biogenexis - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.